Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. / Søgaard, Rikke; Fischer, Barbara Malene B; Mortensen, Jann; Højgaard, Liselotte; Lassen, Ulrik.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, No. 5, 2011, p. 802-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Søgaard, R, Fischer, BMB, Mortensen, J, Højgaard, L & Lassen, U 2011, 'Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial', European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 5, pp. 802-9. https://doi.org/10.1007/s00259-010-1703-y

APA

Søgaard, R., Fischer, B. M. B., Mortensen, J., Højgaard, L., & Lassen, U. (2011). Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. European Journal of Nuclear Medicine and Molecular Imaging, 38(5), 802-9. https://doi.org/10.1007/s00259-010-1703-y

Vancouver

Søgaard R, Fischer BMB, Mortensen J, Højgaard L, Lassen U. Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. European Journal of Nuclear Medicine and Molecular Imaging. 2011;38(5):802-9. https://doi.org/10.1007/s00259-010-1703-y

Author

Søgaard, Rikke ; Fischer, Barbara Malene B ; Mortensen, Jann ; Højgaard, Liselotte ; Lassen, Ulrik. / Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. In: European Journal of Nuclear Medicine and Molecular Imaging. 2011 ; Vol. 38, No. 5. pp. 802-9.

Bibtex

@article{dcbd3082909443dfb971768f8a3189fd,
title = "Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial",
abstract = "Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.",
author = "Rikke S{\o}gaard and Fischer, {Barbara Malene B} and Jann Mortensen and Liselotte H{\o}jgaard and Ulrik Lassen",
year = "2011",
doi = "http://dx.doi.org/10.1007/s00259-010-1703-y",
language = "English",
volume = "38",
pages = "802--9",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

AU - Søgaard, Rikke

AU - Fischer, Barbara Malene B

AU - Mortensen, Jann

AU - Højgaard, Liselotte

AU - Lassen, Ulrik

PY - 2011

Y1 - 2011

N2 - Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.

AB - Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.

U2 - http://dx.doi.org/10.1007/s00259-010-1703-y

DO - http://dx.doi.org/10.1007/s00259-010-1703-y

M3 - Journal article

VL - 38

SP - 802

EP - 809

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 5

ER -

ID: 40161630